E1-3s

N/A

Report date: 2026/03/19 16:58:36

Base Information

Drug NameE1-3s
Drug Alias Nametrop-2/CD-3 trivalent bispecific antibody (Immunomedics/IBC Pharmaceuticals)Anti-CD3/Anti-Trop-2 Trivalent Bispecific T-Cell Engager (Immunomedics/IBC Pharmaceuticals)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionTumor-associated calcium signal transducer 2 modulatorsT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3Tumor-associated calcium signal transducer 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIbc Pharmaceuticals IncImmunomedics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A